Published in J Natl Cancer Inst on July 08, 2008
Increasing value and reducing waste: addressing inaccessible research. Lancet (2014) 4.83
Systematic evaluation of environmental factors: persistent pollutants and nutrients correlated with serum lipid levels. Int J Epidemiol (2012) 2.42
A nutrient-wide association study on blood pressure. Circulation (2012) 2.19
Tracking replicability as a method of post-publication open evaluation. Front Comput Neurosci (2012) 1.56
Data sharing: not as simple as it seems. Environ Health (2011) 1.40
Endogenous versus exogenous DNA adducts: their role in carcinogenesis, epidemiology, and risk assessment. Toxicol Sci (2010) 1.40
Epidemiology, public health, and the rhetoric of false positives. Environ Health Perspect (2009) 1.37
Lifetime exposure to arsenic in drinking water and bladder cancer: a population-based case-control study in Michigan, USA. Cancer Causes Control (2010) 1.13
Data-driven integration of epidemiological and toxicological data to select candidate interacting genes and environmental factors in association with disease. Bioinformatics (2012) 1.06
IARC monographs: 40 years of evaluating carcinogenic hazards to humans. Environ Health Perspect (2015) 1.03
Bayesian bias adjustments of the lung cancer SMR in a cohort of German carbon black production workers. J Occup Med Toxicol (2010) 1.00
Recommendations and proposed guidelines for assessing the cumulative evidence on joint effects of genes and environments on cancer occurrence in humans. Int J Epidemiol (2012) 0.99
Why selective publication of statistically significant results can be effective. PLoS One (2013) 0.97
Up from 'false positives' in genetic-and other-epidemiology. Eur J Epidemiol (2008) 0.97
Assessment of vibration of effects due to model specification can demonstrate the instability of observational associations. J Clin Epidemiol (2015) 0.93
TCDD and cancer: a critical review of epidemiologic studies. Crit Rev Toxicol (2011) 0.92
Identifying an indoor air exposure limit for formaldehyde considering both irritation and cancer hazards. Crit Rev Toxicol (2011) 0.88
Appropriate epidemiologic methods as a prerequisite for valid study results. Eur J Epidemiol (2008) 0.88
The health impacts of semiconductor production: an epidemiologic review. Int J Occup Environ Health (2013) 0.87
Association between Parkinson's Disease and Cigarette Smoking, Rural Living, Well-Water Consumption, Farming and Pesticide Use: Systematic Review and Meta-Analysis. PLoS One (2016) 0.85
A proposal for assessing study quality: Biomonitoring, Environmental Epidemiology, and Short-lived Chemicals (BEES-C) instrument. Environ Int (2014) 0.83
Field-wide meta-analyses of observational associations can map selective availability of risk factors and the impact of model specifications. J Clin Epidemiol (2015) 0.81
A Critical Assessment of Epidemiology Studies Regarding Dietary/Supplemental Zinc and Prostate Cancer Risk. Open Urol Nephrol J (2008) 0.80
Epidemiology, public health, and false-positive results: the role of the clinicians and pathologists. Environ Health Perspect (2010) 0.78
Re: False-positive results in cancer epidemiology: a plea for epistemological modesty. J Natl Cancer Inst (2009) 0.77
Coffee and caffeine intake and risk of endometriosis: a meta-analysis. Eur J Nutr (2014) 0.77
Use & Misuse of Water-filtered Tobacco Smoking Pipes in the World. Consequences for Public Health, Research & Research Ethics. Open Med Chem J (2015) 0.76
Application environmental epidemiology to vehicular air pollution and health effects research. Indian J Occup Environ Med (2015) 0.75
Re: False-positive results in cancer epidemiology: a plea for epistemological modesty. J Natl Cancer Inst (2009) 0.75
Tobacco smoking and risk of endometriosis: a systematic review and meta-analysis. BMJ Open (2014) 0.75
Re: False-positive results in cancer epidemiology: a plea for epistemological modesty. J Natl Cancer Inst (2009) 0.75
Is uncertainty in complex disease epidemiology resolvable? Emerg Themes Epidemiol (2015) 0.75
Cancer genetic association studies in the genome-wide age. Per Med (2008) 0.75
Effectiveness of strategies to increase the validity of findings from association studies: size vs. replication. BMC Med Res Methodol (2010) 0.75
Perlite toxicology and epidemiology--a review. Inhal Toxicol (2014) 0.75
Taking action on developmental toxicity: scientists' duties to protect children. Environ Health (2012) 0.75
Mortality and cancer morbidity among cement production workers: a meta-analysis. Int Arch Occup Environ Health (2016) 0.75
Enigmas, priorities and opportunities in cancer epidemiology. Eur J Epidemiol (2017) 0.75
Lack of association between occupational exposure to diesel exhaust and risk of pancreatic cancer: a systematic evaluation of available data. Int Arch Occup Environ Health (2013) 0.75
Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature (2007) 144.95
Meta-analysis in clinical trials. Control Clin Trials (1986) 144.91
Operating characteristics of a rank correlation test for publication bias. Biometrics (1994) 47.97
Why most published research findings are false. PLoS Med (2005) 41.68
Assessing the probability that a positive report is false: an approach for molecular epidemiology studies. J Natl Cancer Inst (2004) 19.00
Replication validity of genetic association studies. Nat Genet (2001) 16.30
A comparison of observational studies and randomized, controlled trials. N Engl J Med (2000) 14.11
Epidemiology faces its limits. Science (1995) 12.39
Contradicted and initially stronger effects in highly cited clinical research. JAMA (2005) 11.15
Blood levels of organochlorine residues and risk of breast cancer. J Natl Cancer Inst (1993) 8.11
Problems of reporting genetic associations with complex outcomes. Lancet (2003) 8.11
Publication and related bias in meta-analysis: power of statistical tests and prevalence in the literature. J Clin Epidemiol (2000) 7.95
Plasma organochlorine levels and the risk of breast cancer. N Engl J Med (1997) 7.02
Comparison of evidence of treatment effects in randomized and nonrandomized studies. JAMA (2001) 5.96
Breast cancer and serum organochlorines: a prospective study among white, black, and Asian women. J Natl Cancer Inst (1994) 5.92
Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. Epidemiology (2007) 5.77
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Epidemiology (2007) 5.12
Issues in the reporting of epidemiological studies: a survey of recent practice. BMJ (2004) 4.69
A Bayesian measure of the probability of false discovery in genetic epidemiology studies. Am J Hum Genet (2007) 4.21
Early extreme contradictory estimates may appear in published research: the Proteus phenomenon in molecular genetics research and randomized trials. J Clin Epidemiol (2005) 4.14
An exploratory test for an excess of significant findings. Clin Trials (2007) 3.83
Coffee and cancer of the pancreas. N Engl J Med (1981) 3.79
Quantitative trait Loci analysis using the false discovery rate. Genetics (2005) 3.69
Genetic associations in large versus small studies: an empirical assessment. Lancet (2003) 3.41
The impact of residual and unmeasured confounding in epidemiologic studies: a simulation study. Am J Epidemiol (2007) 3.40
DDT and breast cancer in young women: new data on the significance of age at exposure. Environ Health Perspect (2007) 3.19
Organochlorine exposure and risk of breast cancer. Lancet (1998) 3.18
Freely associating. Nat Genet (1999) 2.91
Breast cancer and abortion: collaborative reanalysis of data from 53 epidemiological studies, including 83?000 women with breast cancer from 16 countries. Lancet (2004) 2.80
False positive outcomes and design characteristics in occupational cancer epidemiology studies. Int J Epidemiol (2001) 2.76
Re-evaluation of some organic chemicals, hydrazine and hydrogen peroxide. Proceedings of the IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Lyon, France, 17-24 February 1998. IARC Monogr Eval Carcinog Risks Hum (1999) 2.69
Induced abortion and risk for breast cancer: reporting (recall) bias in a Dutch case-control study. J Natl Cancer Inst (1996) 2.36
Methodological issues regarding confounding and exposure misclassification in epidemiological studies of occupational exposures. Am J Ind Med (2007) 2.33
Is this clinical trial fully registered? A statement from the International Committee of Medical Journal Editors. Lancet (2005) 2.15
Pesticides and polychlorinated biphenyl residues in human breast lipids and their relation to breast cancer. Arch Environ Health (1992) 2.10
1,1-Dichloro-2,2-bis(p-chlorophenyl)ethylene and polychlorinated biphenyls and breast cancer: combined analysis of five U.S. studies. J Natl Cancer Inst (2001) 2.05
Parameters for reliable results in genetic association studies in common disease. Nat Genet (2002) 2.00
Believability of relative risks and odds ratios in abstracts: cross sectional study. BMJ (2006) 1.89
The epidemiology of cervical carcinogenesis. Cancer (1995) 1.88
Occupational exposure to vinyl chloride, acrylonitrile and styrene and lung cancer risk (europe). Cancer Causes Control (2004) 1.80
Risk of breast cancer and organochlorine exposure. Cancer Epidemiol Biomarkers Prev (2000) 1.70
Organochlorine exposures and breast cancer risk in New York City women. Environ Res (2000) 1.67
Serum concentrations of organochlorine compounds and the subsequent development of breast cancer. Cancer Epidemiol Biomarkers Prev (1999) 1.57
Environmental toxins and breast cancer on Long Island. II. Organochlorine compound levels in blood. Cancer Epidemiol Biomarkers Prev (2002) 1.50
Coffee, tea, mate, methylxanthines and methylglyoxal. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Lyon, 27 February to 6 March 1990. IARC Monogr Eval Carcinog Risks Hum (1991) 1.39
Environmental organochlorine exposure and postmenopausal breast cancer risk. Cancer Epidemiol Biomarkers Prev (1998) 1.30
Epidemiology of pancreas cancer (1988). Int J Pancreatol (1989) 1.27
Response bias in a case-control study: analysis utilizing comparative data concerning legal abortions from two independent Swedish studies. Am J Epidemiol (1991) 1.26
Dichlorodiphenyldichloroethane burden and breast cancer risk: a meta-analysis of the epidemiologic evidence. Environ Health Perspect (2004) 1.25
Risk of female breast cancer associated with serum polychlorinated biphenyls and 1,1-dichloro-2,2'-bis(p-chlorophenyl)ethylene. Cancer Epidemiol Biomarkers Prev (2000) 1.24
Serum organochlorine pesticides and PCBs and breast cancer risk: results from a prospective analysis (USA). Cancer Causes Control (1999) 1.21
Organochlorine compounds in human breast fat from deceased with and without breast cancer and in a biopsy material from newly diagnosed patients undergoing breast surgery. Environ Res (1984) 1.17
Plasma organochlorine levels and the risk of breast cancer: an extended follow-up in the Nurses' Health Study. Int J Cancer (2001) 1.13
Serum organochlorine levels and breast cancer: a nested case-control study of Norwegian women. Cancer Epidemiol Biomarkers Prev (2000) 1.13
Occurrence of beta-hexachlorocyclohexane in breast cancer patients. Cancer (1990) 1.12
Organochlorine compounds in neoplastic and adjacent apparently normal breast tissue. Bull Environ Contam Toxicol (1976) 1.11
Epidemiologic study of workers exposed to acrylonitrile. J Occup Med (1980) 1.08
Mortality of industrial workers exposed to acrylonitrile. Scand J Work Environ Health (1998) 1.00
IARC monographs on the evaluation of the carcinogenic risk of chemicals to humans: some monomers, plastics and synthetic elastomers, and acrolein. IARC Monogr Eval Carcinog Risk Chem Hum (1979) 0.96
Pesticide residues and breast cancer: the harvest of a silent spring? J Natl Cancer Inst (1993) 0.92
A mortality survey of employees engaged in the development or manufacture of styrene-based products. J Occup Med (1980) 0.91
The future of epidemiology. BMJ (1996) 0.90
Confidence intervals and P-values for meta-analysis with publication bias. Biometrics (2007) 0.90
Mortality of United Kingdom acrylonitrile polymerisation workers. Br J Ind Med (1981) 0.83
Epidemiologic study of workers exposed to acrylonitrile: an update. J Occup Med (1985) 0.81
Cancer incidence and mortality among workers exposed to acrylonitrile. Am J Ind Med (1987) 0.81
Mortality and morbidity of workers exposed to acrylonitrile in fiber production. Scand J Work Environ Health (1998) 0.80
[Mortality study in chemical personnel of various industries exposed to acrylonitrile]. Zentralbl Arbeitsmed Arbeitsschutz Prophyl Ergonomie (1980) 0.80
Mortality patterns among employees exposed to acrylonitrile. J Occup Med (1989) 0.79
Mortality of workers exposed to acrylonitrile. J Occup Med (1992) 0.79
[Acrylonitrile--epidemiological study--Bayer 1977: a report on a prospective epidemiological study with a past beginning of coworkers at the Leverkusen plant of Bayer AG with acrylonitrile (ACN) exposure]. Zentralbl Arbeitsmed Arbeitsschutz Prophyl (1979) 0.79
Mortality of United Kingdom acrylonitrile workers--an extended and updated study. Scand J Work Environ Health (1998) 0.79
Mortality among rubber workers: VI. Men with potential exposure to acrylonitrile. J Occup Med (1982) 0.79
Mortality update of workers exposed to acrylonitrile in The Netherlands. Scand J Work Environ Health (1998) 0.79
Mortality from tumours in workers in an acrylic fibre factory. Occup Med (Lond) (1993) 0.79
Large-scale genotyping identifies 41 new loci associated with breast cancer risk. Nat Genet (2013) 8.24
Disparities in breast cancer mortality trends between 30 European countries: retrospective trend analysis of WHO mortality database. BMJ (2010) 7.00
A meta-analysis of alcohol consumption and the risk of 15 diseases. Prev Med (2004) 6.24
Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array. Nat Genet (2013) 5.58
Aspirin and non-steroidal anti-inflammatory drugs for cancer prevention: an international consensus statement. Lancet Oncol (2009) 5.05
The false-positive to false-negative ratio in epidemiologic studies. Epidemiology (2011) 4.93
Merging and emerging cohorts: not worth the wait. Nature (2007) 4.66
Alcohol drinking in never users of tobacco, cigarette smoking in never drinkers, and the risk of head and neck cancer: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium. J Natl Cancer Inst (2007) 4.55
Epidemiology and risk factors of urothelial bladder cancer. Eur Urol (2012) 4.45
Risk factors for falls in community-dwelling older people: a systematic review and meta-analysis. Epidemiology (2010) 3.86
The epidemiology of renal cell carcinoma. J Urol (2006) 3.85
Autoimmune disorders and risk of non-Hodgkin lymphoma subtypes: a pooled analysis within the InterLymph Consortium. Blood (2008) 3.81
Recent patterns in gastric cancer: a global overview. Int J Cancer (2009) 3.75
Detectable clonal mosaicism and its relationship to aging and cancer. Nat Genet (2012) 3.69
Detectable clonal mosaicism from birth to old age and its relationship to cancer. Nat Genet (2012) 3.68
Southern community cohort study: establishing a cohort to investigate health disparities. J Natl Med Assoc (2005) 3.67
Obesity and risk for chronic renal failure. J Am Soc Nephrol (2006) 3.67
Increased risk of noncardia gastric cancer associated with proinflammatory cytokine gene polymorphisms. Gastroenterology (2003) 3.58
Cancer risk among statin users: a population-based cohort study. Int J Cancer (2005) 3.50
A common variant at the TERT-CLPTM1L locus is associated with estrogen receptor-negative breast cancer. Nat Genet (2011) 3.37
Randomized double-blind factorial trial of three treatments to reduce the prevalence of precancerous gastric lesions. J Natl Cancer Inst (2006) 3.36
Interaction between tobacco and alcohol use and the risk of head and neck cancer: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium. Cancer Epidemiol Biomarkers Prev (2009) 3.33
Gallbladder cancer worldwide: geographical distribution and risk factors. Int J Cancer (2006) 3.27
Maternal use of selective serotonin reuptake inhibitors and risk of congenital malformations. Epidemiology (2006) 3.23
Coffee drinking and hepatocellular carcinoma risk: a meta-analysis. Hepatology (2007) 3.22
'Environment' in cancer causation and etiological fraction: limitations and ambiguities. Carcinogenesis (2007) 3.20
Cigarette smoking, body mass index, and stressful life events as risk factors for psoriasis: results from an Italian case-control study. J Invest Dermatol (2005) 3.18
Population attributable risks of esophageal and gastric cancers. J Natl Cancer Inst (2003) 3.07
The landscape of recombination in African Americans. Nature (2011) 3.06
Perfluorinated chemicals and fetal growth: a study within the Danish National Birth Cohort. Environ Health Perspect (2007) 3.03
Use of 5-alpha-reductase inhibitors for prostate cancer chemoprevention: American Society of Clinical Oncology/American Urological Association 2008 Clinical Practice Guideline. J Clin Oncol (2009) 2.95
Genome-wide association study of prostate cancer in men of African ancestry identifies a susceptibility locus at 17q21. Nat Genet (2011) 2.70
Helicobacter pylori infection and gastric atrophy: risk of adenocarcinoma and squamous-cell carcinoma of the esophagus and adenocarcinoma of the gastric cardia. J Natl Cancer Inst (2004) 2.63
Smoking in Italy 2005-2006: effects of a comprehensive National Tobacco Regulation. Prev Med (2007) 2.61
Clinical utility of a plasma-based miRNA signature classifier within computed tomography lung cancer screening: a correlative MILD trial study. J Clin Oncol (2014) 2.57
Trends in the incidence of testicular germ cell tumors in the United States. Cancer (2003) 2.45
The Southern Community Cohort Study: investigating health disparities. J Health Care Poor Underserved (2010) 2.44
Dietary zinc and prostate cancer risk: a case-control study from Italy. Eur Urol (2007) 2.41
Risk of new cancers after radiotherapy in long-term survivors of retinoblastoma: an extended follow-up. J Clin Oncol (2005) 2.37
A further plea for adherence to the principles underlying science in general and the epidemiologic enterprise in particular. Int J Epidemiol (2009) 2.35
Cellular telephone use and cancer risk: update of a nationwide Danish cohort. J Natl Cancer Inst (2006) 2.33
Risk of soft tissue sarcomas by individual subtype in survivors of hereditary retinoblastoma. J Natl Cancer Inst (2007) 2.32
Risk of prostate, breast and colorectal cancer after skin cancer diagnosis. Int J Cancer (2008) 2.28
Progress in chemoprevention drug development: the promise of molecular biomarkers for prevention of intraepithelial neoplasia and cancer--a plan to move forward. Clin Cancer Res (2006) 2.24
Comparing diabetes prevalence between African Americans and Whites of similar socioeconomic status. Am J Public Health (2007) 2.24
Review of epidemiologic studies of dietary acrylamide intake and the risk of cancer. Eur J Cancer Prev (2012) 2.19
Risk factors for thyroid cancer: an epidemiological review focused on nutritional factors. Cancer Causes Control (2008) 2.17
Worldwide mortality from cirrhosis: an update to 2002. J Hepatol (2007) 2.16
Vinyl chloride exposure and cirrhosis: a systematic review and meta-analysis. Dig Liver Dis (2012) 2.15
Mechanisms of disease: The epidemiology of bladder cancer. Nat Clin Pract Urol (2006) 2.13
Trends in mortality from hepatocellular carcinoma in Europe, 1980-2004. Hepatology (2008) 2.11
Carbonated soft drink consumption and risk of esophageal adenocarcinoma. J Natl Cancer Inst (2006) 2.08
Epidemiology and aetiology of gestational trophoblastic diseases. Lancet Oncol (2003) 2.03
The burden of cancer attributable to alcohol drinking. Int J Cancer (2006) 2.01
Non-Hodgkin lymphoma and obesity: a pooled analysis from the InterLymph Consortium. Int J Cancer (2008) 2.01
Helicobacter pylori protein-specific antibodies and risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev (2013) 2.01
The Björk-Shiley convexo-concave heart valve experience from the perspective of the supervisory panel. Am J Cardiol (2013) 2.00
A rebuttal: secret ties to industry and conflicting interests in cancer research. Am J Ind Med (2007) 1.99
Ovarian cancer in Europe: Cross-sectional trends in incidence and mortality in 28 countries, 1953-2000. Int J Cancer (2005) 1.98
Obesity is associated with an increased risk of monoclonal gammopathy of undetermined significance among black and white women. Blood (2010) 1.98
A functional polymorphism of toll-like receptor 4 gene increases risk of gastric carcinoma and its precursors. Gastroenterology (2006) 1.98
Risk of hospitalization for myocardial infarction among users of rofecoxib, celecoxib, and other NSAIDs: a population-based case-control study. Arch Intern Med (2005) 1.98
Relation of dietary glycemic load with ischemic and hemorrhagic stroke: a cohort study in Greece and a meta-analysis. Eur J Nutr (2014) 1.98
The natural history of chronic renal failure: results from an unselected, population-based, inception cohort in Sweden. Am J Kidney Dis (2005) 1.97
Total exposure and exposure rate effects for alcohol and smoking and risk of head and neck cancer: a pooled analysis of case-control studies. Am J Epidemiol (2009) 1.97
Time from adenosine di-phosphate receptor antagonist discontinuation to coronary bypass surgery in patients with acute coronary syndrome: meta-analysis and meta-regression. Int J Cardiol (2013) 1.94
Evaluation of 11 breast cancer susceptibility loci in African-American women. Cancer Epidemiol Biomarkers Prev (2009) 1.90
Mortality from cardiovascular and cerebrovascular diseases in Europe and other areas of the world: an update. Eur J Cardiovasc Prev Rehabil (2009) 1.90
Fifteen-year effects of Helicobacter pylori, garlic, and vitamin treatments on gastric cancer incidence and mortality. J Natl Cancer Inst (2012) 1.88
Coffee reduces risk for hepatocellular carcinoma: an updated meta-analysis. Clin Gastroenterol Hepatol (2013) 1.87
Cigarette smoking and risk of non-Hodgkin lymphoma: a pooled analysis from the International Lymphoma Epidemiology Consortium (interlymph). Cancer Epidemiol Biomarkers Prev (2005) 1.87
Circulating adiponectin and endometrial cancer risk. J Clin Endocrinol Metab (2004) 1.86
Vitamin D insufficiency among African-Americans in the southeastern United States: implications for cancer disparities (United States). Cancer Causes Control (2008) 1.86
Lung cancer rates convergence in young men and women in the United States: analysis by birth cohort and histologic type. Int J Cancer (2003) 1.85
Trends in mortality from urologic cancers in Europe, 1970-2008. Eur Urol (2011) 1.85
Annual or biennial CT screening versus observation in heavy smokers: 5-year results of the MILD trial. Eur J Cancer Prev (2012) 1.82
Trends in prostate cancer mortality among black men and white men in the United States. Cancer (2003) 1.82
Confounding by indication in epidemiologic studies of commonly used analgesics. Am J Ther (2002) 1.82
A meta-analysis identifies new loci associated with body mass index in individuals of African ancestry. Nat Genet (2013) 1.82
Liver cancer: descriptive epidemiology and risk factors other than HBV and HCV infection. Cancer Lett (2008) 1.80
Cancer risk associated with alcohol and tobacco use: focus on upper aero-digestive tract and liver. Alcohol Res Health (2006) 1.80
Cancer risk associated with use of metformin and sulfonylurea in type 2 diabetes: a meta-analysis. Oncologist (2012) 1.79
Trends in oesophageal cancer incidence and mortality in Europe. Int J Cancer (2008) 1.78